Cell & Bioscience · 2024 · 10 citations · 168 references
Life SciencesNeuroscienceOphthalmologyMolecular NeuroscienceNeurodegenerationSignal TransductionAge-related Macular DegenerationDiabetic RetinopathyMacular DegenerationMacular DisordersRetinal DegenerationRetinal DiseaseDiabetic Retinopathy NeurobiologyRetinal Degeneration MechanismsRetinal Disease MechanismsRetinal Ganglion Cell Disease MechanismsRetinal Ganglion Cell Survival SignalingRetinal PharmacologyRetinitis Pigmentosa TherapyTherapeutic Trials
sensor has garnered abundant research interest in the domain of neurodegeneration. Accumulating evidences suggest that CaMKII is implicated in the pathology of degenerative retinopathies such as diabetic retinopathy (DR), age-related macular degeneration (AMD), retinitis pigmentosa (RP) and glaucoma optic neuropathy. CaMKII can induce the aberrant proliferation of retinal blood vessels, influence the synaptic signaling, and exert dual effects on the survival of retinal ganglion cells and pigment epithelial cells. Researchers have put forth multiple therapeutic agents, encompassing small molecules, peptides, and nucleotides that possess the capability to modulate CaMKII activity. Due to its broad range isoforms and splice variants therapeutic strategies seek to inhibit specifically the CaMKII are confronted with considerable challenges. Therefore, it becomes crucial to discern the detrimental and advantageous aspects of CaMKII, thereby facilitating the development of efficacious treatment. In this review, we summarize recent research findings on the cellular and molecular biology of CaMKII, with special emphasis on its metabolic and regulatory mechanisms. We delve into the involvement of CaMKII in the retinal signal transduction pathways and discuss the correlation between CaMKII and calcium overload. Furthermore, we elaborate the therapeutic trials targeting CaMKII, and introduce recent developments in the zone of CaMKII inhibitors. These findings would enrich our knowledge of CaMKII, and shed light on the development of a therapeutic target for degenerative retinopathy.
168
SNAREpins: Minimal Machinery for Membrane Fusion
Thomas Weber, Boris V. Zemelman, James A. McNew et al. · Cell · 1998 · 2.5K citations · Full text
PI3K/AKT/mTOR Pathway in Angiogenesis
Jayashree Karar, Amit Maity · Frontiers in Molecular Neuroscience · 2011 · 1.5K citations · Full text
A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation
Jeffrey R. Erickson, Mei-ling A. Joiner, Xiaoqun Guan et al. · Cell · 2008 · 1.1K citations · Full text